Navigation Links
Anti-HIV gel shows promise in large-scale study in women
Date:2/9/2009

An investigational vaginal gel intended to prevent HIV infection in women has demonstrated encouraging signs of success in a clinical trial conducted in Africa and the United States. Findings of the recently concluded study, funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, were presented today at the Conference on Retroviruses and Opportunistic Infections in Montreal.

The study investigators found the microbicide gelknown as PRO 2000 (Indevus Pharmaceuticals, Inc., Lexington, Mass.)to be safe and approximately 30 percent effective (33 percent effectiveness would have been considered statistically significant). This is the first human clinical study to suggest that a microbicidea gel, foam or cream intended to prevent the sexual transmission of HIV and other sexually transmitted infections when applied topically inside the vagina or rectummay prevent male-to-female sexual transmission of HIV infection.

"Although more data are needed to conclusively determine whether PRO 2000 protects women from HIV infection, the results of this study are encouraging," says NIAID Director Anthony S. Fauci, M.D.

The Phase II/IIb clinical trial, which enrolled more than 3,000 women, is NIH's first large clinical study of a microbicide.

"An effective microbicide would be a valuable tool that women could use to protect themselves against HIV and one that could substantially reduce the number of new HIV infections worldwide," Dr. Fauci adds.

"The study, while not conclusive, provides a glimmer of hope to millions of women at risk for HIV, especially young women in Africa," adds lead investigator Salim S. Abdool Karim, MBChB, Ph.D., from the Center for the AIDS Program of Research in South Africa, who presented the findings at CROI. "It provides the first signal that a microbicide gel may be able to protect women from HIV infection."

Currently, women make up half of all people worldwi
'/>"/>

Contact: Kathy Stover
stoverk@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Clues to ensuring anti-HIV drugs are taken in Africa
2. Anti-HIV gel proven safe, tolerable for women
3. ImQuest Presents New Anti-HIV Drug and Topical Microbicide Development Results on Lead Pyrimidinedione Products IQP-0410 and IQP-0528
4. New study shows promise in reducing surgical risks associated with surgical bleeding
5. New research shows how chronic stress worsens neurodegenerative disease course
6. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
7. Circulating fats kill transplanted pancreas cells, study shows
8. New Heart Pump Shows Promise in Trial
9. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
10. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
11. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... , ... Specialty Technical Publishers (STP) and Specialty Technical Consultants ... EHS audit protocol for the European Union. Leading companies around the world use ... and rapidly collect, share, archive, and export audit findings in a cost-effective manner. ...
(Date:9/1/2015)... ... September 01, 2015 , ... Curly Hair Solutions™ is thrilled ... highly anticipated partnership between Curly Hair Solutions™ and Trade Secrets allows for nationwide ... and the Curly Hair Solutions™ team could not be more delighted to see ...
(Date:8/31/2015)... TN (PRWEB) , ... September 01, 2015 , ... The ... and other clinically relevant measures for physical therapy patients. The Registry is being developed ... of FOTO, Inc. stated "We are happy to be selected to contribute FOTO Outcomes ...
(Date:8/31/2015)... ... August 31, 2015 , ... Jvion, the Atlanta-based leader in ... case focused on helping hospital perform under the Center for Medicare & Medicaid ... adjusted based on performance across four domains related to care quality. To receive ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... potential patients the resources they need to have a successful cosmetic procedure; from ... plastic surgeons; Cosmetic Town Journal is always ready to help. , It is ...
Breaking Medicine News(10 mins):Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 3Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 4Health News:Curly Hair Solutions™ Partners With Trade Secrets 2Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2Health News:Jvion Releases Value-Based Purchasing Predictive Use Case 2Health News:Cosmetic Town: A One Stop Plastic Surgery Community 2
... YORK (Sept. 20, 2007) -- Easily accessed and plentiful, adult ... be used to create a wide range of tissue types ... for more controversial embryonic stem cells. , That,s the promise ... from Weill Cornell Medical College in New York City, who ...
... library patrons,worldwide will have greater access to the ... products since these,products are now aligned with international ... used and accepted MARC 21 standards, McGraw-Hill,Professional is ... titles onto their Online Public Access Catalogs with ...
... Two-Way American Sign Language Support, WASHINGTON, Sept. ... deaf or hard of hearing can now communicate ... American Sign Language. The new option for ... here and in Maryland, Virginia and West Virginia.,Customers ...
... LLC,continues its growth, by welcoming several leading employee ... to include these seasoned,professionals to enhance our core ... for our collective clients," says J. Scott Schanen, ... benefits brokerage,and consultancy firm focused on performance based ...
... JACKSONVILLE, Fla. -- As many as one in four ... their upper abdomen, and physicians have almost nothing to ... in a small but novel study, researchers have found ... the upper intestine of affected individuals, which suggests a ...
... Sept. 19 Billian,s HealthDATA, the industry,s,only end-to-end ... that they have recently completed the updates to ... In addition to the updated,information about the facilities ... dramatic increase in the number of overall contacts ...
Cached Medicine News:Health News:Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration 2Health News:Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration 3Health News:Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration 4Health News:McGraw-Hill Professional Enhances Library Access to Medical and Engineering Resources 2Health News:Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region 2Health News:Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region 3Health News:Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region 4Health News:Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region 5Health News:Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region 6Health News:Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region 7Health News:Common abdominal pain may be due to a potentially treatable newly recognized inflammatory reaction 2Health News:Billian's HealthDATA Completes Comprehensive Long Term Care Database Update 2
(Date:8/31/2015)... 2015 Regen BioPharma, Inc. (OTCBB: RGBP) ... novel means of delivering its patented (US Patent ... tumors utilizing a clinically approved formulation as delivery ... with gene silencing therapeutics in which the gene ... whole body.  By utilizing a local delivery system, ...
(Date:8/31/2015)... and MOUNTAIN VIEW, Calif. , Aug. ... ; EURONEXT: SAN) and the life sciences team at ... care and outcomes for people with type 1 and ... treatments and devices with Google,s expertise in analytics, miniaturized ... explore how to improve diabetes care by developing new ...
(Date:8/31/2015)...  Qualcomm Incorporated (NASDAQ: QCOM ) today ... is collaborating with Davita Healthcare Partners and ... by Qualcomm Life,s 2net™ Device Connectivity Platform and ... informed interventions and better management of at-risk populations. ... Connect 2015 ecosystem conference taking place ...
Breaking Medicine Technology:Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
... 7, 2011  Tethys Bioscience has entered into an agreement ... employers measurably flatten the trajectory of their healthcare trends ... their employee populations. The agreement allows ACAP Health to ... as a component of its disease intervention programs. The ...
... 2011 Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE ... and develops new uses for previously approved drugs and ... of the granting of a European patent with broad ... diketopiperazine which is the active ingredient of Ampion™.  The ...
Cached Medicine Technology:Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes 2Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes 3Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion™ 2
Open blade design with aspiration capabilities for removing fluids from the operative site. 19 gauge wire....
Designed to provide open approaches of the keratome to the cornea for either the left or right eye. Lightweight wire design adds to the comfort of the instrument when in place....
Solid 14 mm free-swinging blades, suture posts, and stabilizing disk. Dull finish....
Designed for use with foster enucleation snare (E3670). Package of 12 stainless steel wires. Overall length 5.3 inches....
Medicine Products: